Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology.
about
Scaling of number, size, and metabolic rate of cells with body size in mammalsNew approaches for precise response evaluation in hepatocellular carcinomaTreatment Response Evaluation and Follow-up in Hepatocellular CarcinomaImaging Cellular Proliferation in Prostate Cancer with Positron Emission TomographyPhosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retentionEffect of Androgen on Normal Biodistribution of [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Athymic Non-tumor-bearing Male Mice.Molecular imaging of metastatic potential.The synthesis of 18F-FDS and its potential application in molecular imaging.Assessment of tracer 99mTc(V)-DMSA uptake as a measure of tumor cell proliferation in vitro.Positron emission tomography imaging of cancer biology: current status and future prospectsApplications of molecular imaging.Imaging for assessment of treatment response in hepatocellular carcinoma: Current update.Molecular imaging of prostate cancer: PET radiotracers.The effects of 5-fluoruracil treatment on 3'-fluoro-3'-deoxythymidine (FLT) transport and metabolism in proliferating and non-proliferating cultures of human tumor cells.[18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations.PET/CT in prostate cancer: non-choline radiopharmaceuticals.Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings[18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study.A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma.PET and SPECT Imaging of Tumor Biology: New Approaches towards Oncology Drug Discovery and Development.Use of nuclear magnetic resonance-based metabolomics in detecting drug resistance in cancerPET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer.18F-FLT and 18F-FDG PET-CT imaging in the evaluation of early therapeutic effects of chemotherapy on Walker 256 tumor-bearing rats.Imaging with non-FDG PET tracers: outlook for current clinical applications.Initial characterization of a dually radiolabeled peptide for simultaneous monitoring of protein targets and enzymatic activity.FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model.Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft model.Metabolic and molecular relative percentage coreduction in patients with locally advanced rectal cancer treated with neoadjuvant therapy.Clinical significance of VEGFR-2 and ¹⁸F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy.Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET.¹⁸F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes.Highly efficient syntheses of [methyl-11C]thymidine and its analogue 4'-[methyl-11C]thiothymidine as nucleoside PET probes for cancer cell proliferation by Pd(0)-mediated rapid C-[11C]methylation.An approach to the asymmetric synthesis of 18F-labeled analog of l-threo-3,4-dihydroxyphenylserine (6-l-threo-[18F]FDOPS) — a new radiotracer for visualization of norepinephrine transporters by positron emission tomographyQ58648366
P2860
Q24673689-CF8FA305-B4E7-4362-933C-B3FCBA8A92A2Q26866367-BB296DED-64F4-45A1-A01F-6F66DE1523ACQ26992004-9E6FC2BB-DAB7-4795-AB2F-0E1D7C88CF89Q28066696-83C82F44-F181-4A25-974A-4866072BB79AQ28540476-502622A9-2CD9-4129-B022-4A99B34C053BQ33601455-E6907B8E-716B-4E7D-9A7B-3E943A5A4DEDQ33917943-EB0ACDDC-B37C-4086-8195-0EA9FD3A5888Q34083386-228817FC-6340-4FEA-AE30-E16D832BB086Q34555868-14B61294-07E6-43AD-AB82-2B4CFF28D883Q34697688-A13D9151-1C4C-40DA-AAC5-7E4CAB83EBEBQ35082412-7384B4CB-40C8-4FE9-8530-F717025DDD83Q35568722-D60E95CA-80FA-4D65-AFE0-BF69E68C98E1Q36129937-1B599750-104E-480F-844A-FDC4C22B9706Q36213599-E63B7A70-3463-48CE-A9A8-15B17108865AQ36236041-52C4AFEC-2CB5-4D39-8220-9333C8AF93EAQ36308766-52C41AB1-B42D-4F91-A39A-C21CA19446A2Q36322912-60A7C74A-43AE-4E5D-BD71-77D082949186Q36626050-E2BAF53E-45CF-4F78-BA32-F8ACA29254CFQ36858129-C8A76794-73AD-46D5-98FB-E4674EFFAA63Q36985532-559C024D-1F58-441B-B890-0ECFE3CA4AC0Q37374442-BFD079C0-C951-427B-872D-36C0728EC8D3Q37374479-0B0753AD-01F3-4E53-B2FF-70EDBEE23593Q37390670-8FADF738-1ABA-468A-B802-C80AD77E58E7Q37581739-B4395B9E-F616-4E46-B22A-908BDF6A0685Q37986065-62A23CD8-7A28-438F-B265-2ADC7DE11E10Q39244267-F32DDB7E-28B8-4B9C-B2B5-4D8C2752AC67Q39397672-FC40D7B3-E424-46F1-8EFD-A82C5FCE4BB2Q39428846-5FD060DB-FBA5-4D9B-A3E0-5B2AF2C342E4Q43345082-B85AA377-8B59-4785-BEF6-939CE532A39BQ50878258-0F1A95BD-7507-4FB0-8241-E4675F69F9BEQ53010775-CF7C8071-FB29-40B0-843A-FD5F2D4C9FC7Q53119631-13572C15-88C5-4C0A-B490-E6BD6EBD1737Q53253258-26AA7F0C-05EF-4F5F-8387-4756F876EE02Q57998776-92712527-BC0C-4218-895B-4F0EAE8BAA88Q58648366-AA910DB0-5159-4D84-8D42-401CFA462D7D
P2860
Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Positron emission tomography m ...... ts expanding role in oncology.
@ast
Positron emission tomography m ...... ts expanding role in oncology.
@en
type
label
Positron emission tomography m ...... ts expanding role in oncology.
@ast
Positron emission tomography m ...... ts expanding role in oncology.
@en
prefLabel
Positron emission tomography m ...... ts expanding role in oncology.
@ast
Positron emission tomography m ...... ts expanding role in oncology.
@en
P2860
P1476
Positron emission tomography m ...... ts expanding role in oncology.
@en
P2093
Anthony F Shields
P2860
P2888
P304
P356
10.1007/S11307-006-0039-2
P577
2006-05-01T00:00:00Z